A Crucial Step for the TB Alliance NC-009 Study
By Gcina Nhleko THINK’s Strategic Partnerships and Community Health Systems Strengthening department recently convened a meeting attended by members representing the leadership of various community groups – Traditional, Religious, Civil Society – and the Department of Health. The meeting's purpose was to harness community relations and to give a broader outline of the TB Alliance NC-OO9 study and trials imperatives THINK is currently conducting. NC-009 is a pan-Phase 2 clinical trial incorporating Phase 2a, b, and c elements. NC-009 aims to evaluate the safety and efficacy of a combination of TBAJ-876, pretomanid, and linezolid for its potential to shorten and [...]
